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ABSTRACT 
G Protein-Coupled Estrogen Receptor is Activated by G-1 Which Induces a Signaling 
Cascade that Inhibits Breast Cancer Cell Proliferation. (May 2012) 
 
Heather Watts 
Department of Veterinary Medicine and Biomedical Sciences 
Texas A&M University 
 
Research Advisor: Dr. Guichun Han 
Department of Veterinary Physiology and Pharmacology 
 
Breast cancer is the most common cancer in women and is predominantly estrogen 
dependent. About 1 in 8 women in the United States (12%) will develop invasive breast 
cancer over the course of her lifetime. Failure in the current treatment of breast cancer 
has led to an increased desire to find the specific mechanism of how cancer cell 
proliferation is inhibited. G protein-coupled estrogen receptor (GPER) is very 
controversial when concerning breast cancer cell proliferation. Some studies report 
evidence that GPER is strongly associated with increased cancer proliferation, 
migration, invasion, differentiation and metastasis. Other studies have found that GPER 
inhibits proliferation of MCF-7 breast cancer cells. The objective of this study was to 
clarify whether GPER works to promote or inhibit MCF-7 breast cancer cell 
proliferation. I found that G-1 (GPER agonist) acted on GPER to inhibit MCF-7 cell 
proliferation. Manual cell counting was used to find the doubling time of the MCF-7 
cells. To determine the effect of G-1 on the cells proliferation I used a cell proliferation 
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assay kit. Through this method it was found that G-1 inhibits proliferation in a 
concentration dependent manner. Western blot was used to detect the target proteins 
such as GPER, ER, ER, p53 and p38. I tested antibody on these cells through Western 
blot and discovered that the correct antibodies were used and p38 and p53 proteins were 
present in the MCF-7 cells. Immunocytochemistry was also used to test specific 
antibodies. Proliferating Cell Nuclear Antigen (PCNA) antibody and -actin antibody 
were tested using this method. These results demonstrated that GPER activation inhibits 
MCF-7 cell proliferation. 
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CHAPTER I 
INTRODUCTION 
Breast cancer is one of the most common human malignancies and the second leading 
cause of cancer-related deaths in women, and its incidence in the developing world is on 
the rise. About 30-40% of women with breast cancer will develop metastasis and 
eventually die from this disease. Unfortunately, breast cancer is particularly challenging, 
because it is highly resistant to radiation and conventional chemotherapeutic agents, and 
such resistance is associated with a poor prognosis for this metastatic disease, 
particularly in hormone receptor-positive breast cancer [1]. There is considerable 
emphasis in searching for novel agents that selectively activate cell death machinery of 
breast cancer cells without producing cytotoxic effects on normal cells [2]. The newly 
reported, membrane-associated G protein-coupled estrogen receptor (GPER) is 
structurally unrelated to nuclear ER or R It has drawn much attention as a potential 
mediator of estrogen action in breast cancer [3]. Estrogen binds to GPER and acts to 
increase breast tissue proliferation. G-1 is a chemical substrate that binds to G protein-
coupled estrogen receptor. G-1 has a similar structure to estrogen which allows it to bind 
to GPER. However G-1 decreases MCF-7 proliferation unlike estrogen. G-1 binds only 
to GPER and not to ER or ER. Therefore ER and ER will not interfere with 
experiments. Activation of ER is known to promote MCF-7 growth [4]. It is not yet  
___________________ 
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known whether ER promotes or inhibits MCF-7 proliferation [4]. When GPER is  
activated it induces a signaling pathway. I would like to determine whether this GPER  
activation will further activate p38 and p53. I hypothesize that GPER will then activate 
p38 to p38 MAPK by phosphorylating it. p38 MAPK will then activate p53 which then 
inhibits MCF-7 proliferation. Studies have shown that incubation of active p38 kinase 
with p53 protein causes the phosphorylation of p53 protein [5]. p53 can cause cells to 
growth arrest at certain stages in the cell cycle, of which the best understood is late G2 
phase arrest [6]. Preliminary data in our lab also shows that GPER slows human and 
porcine coronary artery smooth muscle cell proliferation at G2 and M phases of the cell 
cycle. Therefore I suspect GPER to inhibit MCF-7 cell proliferation at G2 and M phases 
as well. 
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CHAPTER II 
 
METHODS 
Cell lines 
MCF-7 cell lines were obtained from American Type Culture Collection and were 
cultured at 37.0°C and 5% CO2. 
Propagation if cells: 
 The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential 
Medium, Catalog No. 30-2003. To make the complete growth medium, I added the 
following components to the base medium: 0.01 mg/ml bovine insulin; fetal bovine 
serum to a final concentration of 10% . 
 
 
Subculturing 
MCF-7 cells are cultured and should be monitored every day for growth. The cells 
should be passed at the appropriate growth levels and should be split into appropriate 
number of dishes to perform Western blot and other experiments.  
Protocol: I strictly followed the protocol given by the manufacturer’s instructions. 
Volumes used in this protocol are for 75 sq cm flasks; proportionally reduce or increase 
amount of dissociation medium for culture vessels of other sizes. 
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1. Remove culture medium to a centrifuge tube. 
2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM EDTA solution 
to remove all traces of serum which contains trypsin inhibitor. 
3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an 
inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). 
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask 
while waiting for the cells to detach. Cells that are difficult to detach may be 
placed at 37C to facilitate dispersal. 
4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently 
pipetting. 
5. Transfer the cell suspension to the centrifuge tube with the medium and cells 
from step 1, and centrifuge at approximately 125 x g for 5 to 10 minutes. Discard 
the supernatant. 
6. Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of 
the cell suspension to new culture vessels. 
7. Incubate cultures at 37C. 
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended  
Medium Renewal: 2 to 3 times per week 
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Cell counting 
A drop of the prepared treatment groups was placed in the sink of a hemocytometer slide 
that enabled cell counting. Typhan Blue dye was used to visualize the cells. By looking 
under a microscope a grid was used to manually count the number of cells. I used three 
dishes of cells and counted them each three times every twenty-four hours for 2 days. I 
was then able to determine the doubling time of the MCF-7 cells. 
 
Cell proliferation assay 
Cell proliferation assay is a good method for evaluating a cell population's response to 
external factors, whether it is an increase in cell growth, no effect, or a decrease in 
growth due to necrosis or apoptosis [3]. I treated the MCF-7 cells with different 
concentrations of G-1 and inserted them into a 96 well plate. I then measured the DNA 
content by using CyQUANT® NF Cell Proliferation Assay Kit (Invitrogen) by 
following the manufactures manual. Data obtained from this will show me how the G-1 
affected the proliferation of MCF-7 cells. 
 
Cell protein assay 
The harvested cells were obtained after incubation and samples were placed in a 96 well 
plate using BCA protein assay according to the manufacturer’s instructions. AlamarBlue 
reagent, BCA protein assay reagent A and BCA protein assay reagent B were added to 
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the wells along with the samples and the well plate was incubated.  The fluorescence 
intensity data was then measured on image J program. The intensity of the fluorescence 
is directly proportional to the number of cells. This data helped determine the volume of 
the samples that should be loaded onto the SDS-PAGE gel. 
 
Western blot 
 Gel electrophoresis was used to separate the proteins. Equal amount of protein (40 or 60 
μg) was subjected to 4-12% SDS–PAGE and electrophoretically transferred to a 
polyvinylidene difluoride membrane. Membranes were blocked, and then incubated with 
anti-α-Actin (1:100), anti--Actin (1:1000), anti-p38 (1:1000), anti-p53 (1:1000), anti-
PCNA (1:100), anti-GPER(1:1000), anti-ER mA1 (1:500), anti-ER21 (1:200), anti-
ER 311 (1:500) antibodies (from Santa Cruz Biotechnology, Abcam, or Cell Signaling) 
overnight, and then with the horseradish peroxidase-conjugated secondary antibody 
(Santa Cruz Biotechnology; 1:5000-10000) for 2 h. These primary antibodies bound to 
their specific target proteins. The secondary antibody bound to the primary antibody 
which then allowed the protein to be seen as bands in imaging. The blot was detected 
with the chemiluminescence detection system. Image J software was used for data 
analysis. Detecting bands in the imaging allowed me to determine if the protein was 
present. I used this Western Blot procedure to determine that p53, p38, GPER, ER, 
ERand actin were present in the MCF-7 cells. 
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Immunocytochemistry 
 Immunocytochemistry is another technique that uses an antibody to detect a specific 
protein antigen. When the antibody binds to the antigen of the protein of interest it stains 
the protein. This protein can then easily be seen using fluorescent light microscopy. 
MCF-7 cells were cultured on 12 mm glass coverslips were serum-starved for 48 h, and 
then treated for 1-2 days in media alone. Cells were then fixed in 10% buffered formalin 
for 10 min, washed twice with PBS, and permeabilized in 0.2% Triton X-100 and PBS 
for 10 min. MCF-7 cells were  washed twice with PBS, and incubated with 4% BSA-
PBS for 1 h and then with anti-α-Actin antibody overnight at 4°C. After three washes 
with PBS, MCF-7 cells were incubated with FITC-conjugated anti-Rabbit IgG antibody 
for 1 h at room temperature in darkness. After three washes with PBS, coverslips were 
mounted for imaging. 
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CHAPTER III 
RESULTS 
MCF-7 doubling time 
I first proceeded by culturing MCF-7 cells. I let the cells grow in the medium while 
changing the medium every few days to ensure optimum growth. I split the cells evenly 
into dishes and counted the cells after 24 hours and 48 hours to monitor the growth and 
determine the doubling time. I observed the cells through an inverted microscope using a 
hemocytometer slide. I counted 2 dishes 3 times after the first 24 hours and got an 
average of 17.5 X 104 and 20.75 X 104 cells in the dishes. I counted 3 dishes after 48 
hours and got an average of 28.6 X 104, 44.16 X104, and 21X104 cells in the dishes. 
From this data indicated in table 1 I determined the doubling time of the MCF-7 cells to 
be 38 hours. Figure 1 shows the MCF-7 cellular concentration graph. These cells were to 
be used for cell proliferation assay, protein assay and Western blot. I had to repeat this 
process several times because I had problems with cell contamination. My averages were 
not always very consistent and I expected my cellular concentrations to be higher than 
they were.  
 
 
 
 
 
 
 
 
9 
 
 
 
Table 1- MCF-7 cellular concentration 
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 24 HOURS 48 HOURS 
DISH 1 AVERAGE 17.75 x 104 28.66 x 104 
DISH 2 AVERAGE 20.75 x 104 44.16 x 104 
DISH 3 AVERAGE  21.00 x 104 
TOTAL AVERAGE 19.25 x 104 31.25 x 104 
Figure 1-MCF-7 doubling time 
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G-1 inhibits MCF-7 proliferation 
The results in Figure 2 were obtained by doing a cellular proliferation assay. Cellular 
concentration assay measured the DNA content of the cells. Certain concentrations of G-
1 were used to treat MCF-7 cells and the proliferation of these cells was measured. 
Dimethyl sulfoxide (DMSO) solvent can be considered a vehicle control. It was tested 
against a standard to make sure that the DMSO solvent does not have an effect on the 
cells. The total DMSO concentration is less than 0.001. This makes DMSO a good 
vehicle control. G-1 concentrations of 10-5, 10-6, 10-7, and 10-8 M were used to treat the 
cells. Through this graph we can see that G-1 treatment inhibits MCF-7 cell proliferation 
by comparing it to the DMSO. G-1 concentration of 10-5 M caused the most inhibition of 
MCF-7 cells. Therefore, when the cells are stimulated with higher concentrations of G-1 
then MCF-7 proliferation decreases. This shows that G-1 inhibits MCF-7 cell 
proliferation in a concentration dependant manner. Table 2 shows the statistical analysis 
of G-1 effect on MCF-7 cell proliferation. The P value for this data is 0.0022, which is 
less than 0.05. P values of less than 0.05 indicate that the results are significant. This 
data shows that G-1 significantly inhibited MCF-7 proliferation.        
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Figure 2- G-1 inhibits MCF-7 cells 
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Table Analyzed 
Data 1   
 
 
   
One-way analysis 
of variance 
   
P value 
0.0022   
 
P value summary **   
 
Are means signif. 
different? (P < 
0.05) Yes   
 
Number of groups 
8   
 
F 
4.384   
 
R square 
0.5229   
 
    
ANOVA Table 
SS df MS 
Treatment 
(between columns) 
2.118e+006 7 302527 
Residual (within 
columns) 
1.932e+006 28 69008 
Total 
4.050e+006 35 
 
 
 
Table 2- Statistical analysis of G-1 effect on MCF-7 cell proliferation 
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MCF-7 expression of p38 and p53 
Using a protein assay gave me the concentration of each sample. The concentration was 
used to find the appropriate volume that should be added to the SDS-PAGE gel. The 
electrophoresis gel separated the proteins according to their molecular weight. The 
proteins on the gel were then transferred to a membrane through Western blot. The 
proteins were then probed with primary antibodies. It is important that the antibody used 
in Western blot be the correct antibody. The antibody has to recognize and bind to 
specific target proteins. When antibodies bind to a target protein, only that protein will 
show up as a band when doing imaging. Figure 3 shows that the p38 antibody and p53 
antibody were the correct antibodies because they detected the target proteins of p38 and 
p53 as seen by the bands. The proteins were detected at the concentrations of 35g and 
50g. -Actin serves as the internal control. This shows that the conditions were good 
and the antibodies were working. When I treat the cells at a later time I now know the 
correct antibodies to use when running the western blot. 
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Figure 3- The expression of p53 and p38 in MCF-7 cells 
 
 
 
 
MCF-7 expression of estrogen receptors 
Figure 4 was obtained through Western blot procedures. HEK293 is the negative control 
and -actin is the internal loading control. GPER antibody was used to determine if the 
MCF-7 cells contained GPER. Based on the band it can be concluded that these cells 
contain GPER. From this we know that the expression of the GPER did not go away 
with the passage of the cells. GPER is also expressed in pig coronary artery smooth 
muscle cells (PCA) and human coronary artery smooth muscle cells (HCSMCs) as 
shown in figure 4. In future experiments I know that GPER is present in these cells and I 
know the correct antibody to use. Therefore, G-1 should be able to bind to GPER when 
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the cells are treated. Without GPER present the signaling cascade desired cannot be 
activated. 
 
 
 
Estrogen receptor ER is known to increase MCF-7 cell proliferation when 
stimulated. ER’s presence in the MCF-7 cells is indicated in Figures 5 and 6. In figure 
5 ER21 antibody binds to ER showing 2 bands responsible for the detection of ER. 
This antibody was used in a 1:200 dilution ratio. This was found using Western blot. The 
bands are detected at 46kD and 66kD. It produced a truncated form of the full length 
ERwhen it forms the 46kD band along with the full length 66kD band. The ER mA1 
Figure 4-GPER expression in MCF-7 cells 
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Figure 5- Two isoforms of ER 
present in MCF-7 cells 
Figure 6- The 66 kD ERexpression in 
MCF-7 cells 
antibody binds to ER and only produces one band, as seen in figure 6. The only band 
detected is the full length, 66kD band. This antibody is used in a 1:500 dilution ratio. 
This shows that the ERconcentration did not fade with passage of the cells. These 
antibodies will be used in future experiments. 
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Figure 7- ER present in MCF-7 cells 
Estrogen receptor  (ER is a classic estrogen nuclear receptor. It is not yet known 
whether its activation promotes or inhibits MCF-7 cellular growth. Figure 7 shows that 
ER is present in the MCF-7 cells using the method of Western blot. ER 311 antibody 
was used at a dilution ratio of 1:500. This antibody bound to ER in the cells; therefore 
ER was not lost with passage of the cells. ER is about 50kD which correctly 
corresponds to what is seen in the band, further confirming the presence of ER. This 
information will be useful in future experiments because I now know the correct 
antibody to be used and I know that ER is found in MCF-7 cells.  
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MCF-7 expression of PCNA and -actin 
Immunocytochemistry is another technique that uses an antibody to detect a specific 
protein antigen. When the antibody binds to the antigen of the protein of interest it stains 
the protein. This protein can then easily be seen using fluorescent light microscopy. 
Proliferating Cell Nuclear Antigen, commonly known as PCNA, is a protein that acts as 
a processivity factor for DNA polymerase in eukaryotic cells. Multiple proteins involved 
in DNA replication, DNA repair, and cell cycle control bind to PCNA rather than 
directly associating with DNA, thus facilitating fast processing of DNA. PCNA protein 
expression is a well-accepted marker of cellular proliferation [5]. This information was 
gathered from Wikipedia. The MCF-7 cells were treated with G-1. PCNA antibody was 
then used. This antibody was used at a dilution ratio of 1:100. The PCNA antibody then 
bound to the MCF-7 cell nucleus and stained only the nucleus. After this was stained the 
proliferation of MCF-7 cells were visualized as seen in figure 8. The next step will be to 
use this method and this antibody to do Flow Cytometry. Flow Cytometry will allow me 
to visualize what step in the cell cycle is inhibited by the action of G-1. 
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 Figure 8-Immunocytochemistry of PCNA in MCF-7 cells 
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-actin antibody was used in immunocytochemistry of MCF-7 cells. The purpose of this 
was to test the -actin antibody. This is another way to see the effect of G-1 on -actin 
other than using Western blot. The MCF-7 cells were treated by G-1. The antibody then 
bound to these cells allowing the cells to be visualized as seen in figure 9. -actin 
antibody was used in a 1:100 dilution ratio. If the proliferation of MCF-7 cells caused by 
G-1 involves changes in -actin florescence, then I will study the mechanism of the 
GPER action. 
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Figure 9- Immunocytochemistry of -actin in MCF-7 cells 
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CHAPTER IV 
SUMMARY AND CONCLUSTIONS 
G protein-coupled estrogen receptor (GPER) is a seven transmembrane domain protein 
that makes a major contribution to the growth regulation of differing normal and cancer 
cells [7,8]. GPER likely plays important roles in modulating estrogen responsiveness and 
in the development and/or progression of hormonally responsive cancers [5]. GPER is a 
source of much controversy; however my study shows that GPER inhibits breast cancer. 
This discovery of GPER’s inhibition of MCF-7 cells makes it a potential therapeutic 
target to combat breast cancer and potentially other types of cancer as well [5]. Others 
believe that GPER increases the proliferation of MCF-7 cells and that blocking (as 
opposed to activating) GPER may prove to be a better strategy for the treatment of 
estrogen-related tumors [9]. However GPER has been shown to decrease the 
proliferative effects of cells of cancers involving not only the breast but also the thyroid, 
ovaries, and prostate [4].  
 
In my experiments I began by culturing MCF-7 cells and monitoring the growth of the 
cells. I counted the cell growth over 24 and 48 hours. This allowed me to get the average 
cellular concentration and doubling time. These cells were then prepared for cell 
proliferation assay, protein assay and Western blot. I then treated the MCF-7 cells with 
different concentrations of G-1. The DNA content in this assay decreased as the 
concentration of G-1 increased, indicating a decreased cellular concentration. This meant 
that higher concentrations of G-1 inhibited MCF-7 proliferation. By using Western blot I 
23 
 
 
 
was able to find the correct primary antibodies that bound to the specific target proteins 
of, p38, p53, GPER, ER, and ER. Knowing these antibodies is necessary when 
performing experiments in the future. This also allowed me to see that the proteins were 
not lost with passage of the cells. At a later time I will test the cross action between 
GPER, ER, and ER and how they function together to effect MCF-7 proliferation. I 
was able to determine the primary antibodies of PCNA and -actin by using the 
immunocytochemistry staining technique. The nucleus of the cells were stained which 
allowed the cells to be easily visualized with a fluorescent microscope. PCNA allows 
you to visualize the proliferation of the cells.  
 
In the near future I will be determining the mechanism of GPER’s role in the inhibition 
of MCF-7 cells by measuring the amounts of p38 and p53 in response to G-1 treatment. 
G-1 binds to only GPER, but not ER or ER. I will be treating the cells with G-1, 
which will activate GPER. When GPER is activated it induces a signaling pathway.  I 
anticipate that GPER will phosphorylate p38 to p38 MAPK. Phosphorylated p38 MAPK 
activates p53 to its active phospho-p53. I anticipate that the phospho p53 stops the MCF-
7 proliferation at G2 and M phases. Flow Cytometry will be used to determine the stage 
of the cell cycle that will be inhibited. I will use protein assay and Western blot to 
monitor the change in the concentrations of proteins when the MCF-7 cells are treated 
with G-1. I expect that when the cells are treated with G-1 the concentration of phospho 
p38 MAPK and phospho p53 will increase leading to a decrease of MCF-7 cell numbers. 
Increasing evidence indicates a central role for p53 in mediating cell cycle arrest or 
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apoptosis [10]. Results from Cellular Proliferation Assay have proved that G-1 treatment 
leads to decreased concentration of MCF-7 cells. G-1 is an agonist of GPER; therefore 
G-1 must have activated GPER which then led to the inhibition of MCF-7 cell 
proliferation. This is further evidence that GPER leads to inhibition of breast cancer. If 
this signaling cascade leading to MCF-7 cellular inhibition proves to be correct then it 
will contribute to the effort in targeting GPER for chemotherapeutic treatment.  
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